Zomedica Corp. (ZOM) is priced at $0.20 after the most recent trading session. At the very opening of the session, the stock price was $0.20 and reached a high price of $0.21, prior to closing the session it reached the value of $0.20. The stock touched a low price of $0.20.Recently in News on November 14, 2022, Zomedica Announces Third Quarter 2022 Financial Results: $4.78 Million Revenue; 75% Gross Margin & $158.49 Million in Cash, Cash Equivalents, and Available-For-Sale Securities. Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or the “Company”, a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, reported consolidated financial results for the three- and nine-month periods ended September 30, 2022. Amounts are presented under accounting principles generally accepted in the United States of America (“U.S. GAAP”). You can read further details here
Zomedica Corp. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.5000 on 02/17/22, with the lowest value was $0.1750 for the same time period, recorded on 05/12/22.
Zomedica Corp. (ZOM) full year performance was -52.84%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Zomedica Corp. shares are logging -59.20% during the 52-week period from high price, and 16.57% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.17 and $0.50.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 8535718 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Zomedica Corp. (ZOM) recorded performance in the market was -33.44%, having the revenues showcasing -28.80% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 198.62M, as it employees total of 47 workers.
Specialists analysis on Zomedica Corp. (ZOM)
During the last month, 0 analysts gave the Zomedica Corp. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.2480, with a change in the price was noted -0.02. In a similar fashion, Zomedica Corp. posted a movement of -7.27% for the period of last 100 days, recording 11,381,662 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ZOM is recording 0.01 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Trends and Technical analysis: Zomedica Corp. (ZOM)
Raw Stochastic average of Zomedica Corp. in the period of last 50 days is set at 8.47%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 9.49%. In the last 20 days, the company’s Stochastic %K was 8.14% and its Stochastic %D was recorded 8.44%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -33.44%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -9.49%, alongside a downfall of -52.84% for the period of the last 12 months. The shares increased approximately by -8.07% in the 7-day charts and went up by -8.52% in the period of the last 30 days. Common stock shares were lifted by -28.80% during last recorded quarter.